Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry|August 13, 2018
Anti-angiogenic and anticancer effects of baicalein derivatives based on transgenic zebrafish modelXueyang Jiang, Junting Zhou, Qinghua Lin, et al.Chemistry & Biodiversity|June 8, 2021
Neuroprotective Activities of Constituents from Phyllosticta capitalensis, an Endophyte Fungus of Loropetalum chinense var. rubrumXiaoxia Zhu, Ying Liu, Yunwei Hu, et al.Expert Opinion on Therapeutic Patents|March 29, 2017
Gamma secretase inhibitors: a patent review (2013 - 2015)Kai Gu, Qi Li, Hongzhi Lin, et al.Bioorganic Chemistry|December 15, 2024
Design, synthesis and biological evaluation of novel pyrazolinone derivatives as multifunctional ligands for the treatment of Alzheimer's diseaseHuabo Wang, Yulu Wu, Anran Liu, et al.Current Pharmaceutical Design|August 14, 2018
The Development of Pharmacophore Modeling: Generation and Recent Applications in Drug DiscoveryXin Lu, Hongyu Yang, Yao Chen, et al.Bioorganic Chemistry|June 30, 2023
Discovery of thiazole salt AChE inhibitors and development of thiamine disulfide prodrugs targeting the central nervous systemChang Liu, Manxing Zou, Jianguo Zuo, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|April 14, 2018
Small molecule KDM4s inhibitors as anti-cancer agentsHongzhi Lin, Qihang Li, Qi Li, et al.European Journal of Medicinal Chemistry|July 1, 2021
Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer's disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestineXueyang Jiang, Chang Liu, Manxing Zou, et al.Future Medicinal Chemistry|May 7, 2021
Synthesis and activity of miconazole derivatives as dual BChE/IDO1 inhibitors for the treatment of Alzheimer's diseaseXin Lu, Yijun Liu, Nan Qin, et al.European Journal of Medicinal Chemistry|September 20, 2020
Rational design and biological evaluation of a new class of thiazolopyridyl tetrahydroacridines as cholinesterase and GSK-3 dual inhibitors for Alzheimer's diseaseXueyang Jiang, Junting Zhou, Yang Wang, et al.Pageof 4